Hydroxylated pyrimidyl cyclopentane as AKT protein kinase inhibitor
US8853216B2 · kind B2 · utility
3Cited by
26References
5Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jan 9, 2009 |
| Grant date | Oct 7, 2014 |
| Priority date | — |
| Expiry date | Mar 31, 2030 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides a compound and pharmaceutically acceptable salts thereof, comprising the Formula I. Also provided are methods of using the compound of this invention as an AKT protein kinase inhibitor and for the treatment of hyperproliferative diseases such as cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.